Showing results (141-150 of 326) with videos related to
Sort By:
Pageof 33
Journal of Cancer Policy|March 5, 2023
Media coverage of cancer therapeutics: A review of literatureFidel Rubagumya, Jacqueline Galica, Eulade Rugengamanzi, et al.JCO Global Oncology|August 1, 2020
Overview of Delivery of Cancer Care in Nepal: Current Status and Future PrioritiesBishal Gyawali, Shubham Sharma, Ramila Shilpakar, et al.JNCI Cancer Spectrum|July 31, 2019
Reliability of Oncology Value Framework Outputs: Concordance Between Independent Research GroupsJoseph C Del Paggio, Sierra Cheng, Christopher M Booth, et al.Gynecologic Oncology|January 28, 2024
Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian CancerGordon Taylor Moffat, Weidong Kong, Helen J MacKay, et al.The Journal of Supportive Oncology|October 20, 2007
Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational studyChristopher M Booth, Mark Clemons, George Dranitsaris, et al.European Journal of Cancer (Oxford, England : 1990)|September 25, 2007
Endpoints and other considerations in phase I studies of targeted anticancer therapy: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)Christopher M Booth, A Hilary Calvert, Giuseppe Giaccone, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, CanadaChristopher M Booth, Frances A Shepherd, Yingwei Peng, et al.JCO Global Oncology|November 6, 2020
Educational Status, Cancer Stage, and Survival in South India: A Population-Based StudyAleyamma Mathew, Preethi Sara George, Ramadas Kunnambath, et al.European Journal of Cancer (Oxford, England : 1990)|September 12, 2007
Design and conduct of phase II studies of targeted anticancer therapy: recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)Christopher M Booth, A Hilary Calvert, Giuseppe Giaccone, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 28, 2021
Use of imaging for active surveillance in testicular cancer: Is real-world practice concordant with guidelines?Bishal Gyawali, Rebecca Griffiths, Andrew G Robinson, et al.Pageof 33